IFNG and neurodegenerative disease: Importantly, some possible future remyelinating therapies for all neurodegenerative diseases that target oligodendrocyte precursor cells (OPCs) differentiation or their IFN-γ and mSOD1 signalling must strictly consider all other phenotypes of glial cells.